Combination Therapies against COVID-19

Area of Science:

• Virology
• Infectious Diseases
• Pharmacology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a global pandemic with severe health and economic impacts.
• The virus targets host cells via receptors like angiotensin converting enzyme 2, leading to diverse symptoms from fever to ARDS.
• Existing treatments aim to disrupt viral replication or manage patient complications.

Purpose of the Study:

• To review and update the progress of combination therapies for COVID-19.
• To focus on treatments incorporating at least one small molecule.
• To provide insights for developing future therapeutic strategies against SARS-CoV-2 and its variants.

Main Methods:

• Literature review of combination therapies for COVID-19.
• Analysis of studies involving small molecule therapeutics.
• Synthesis of current treatment approaches and their efficacy.

Main Results:

• Overview of various combination therapies targeting different stages of the viral life cycle.
• Discussion of small molecule agents in combination treatment regimens.
• Identification of promising therapeutic strategies for managing COVID-19.

Conclusions:

• Combination therapies, particularly those with small molecules, show promise in combating COVID-19.
• Further research into these combination strategies is crucial for developing effective treatments against current and future SARS-CoV-2 variants.